Douglas Tsao analyst HC WAINWRIGHT

Currently, out of the existing stock ratings of Douglas Tsao - 46 which are a Hold (19.25%), 189 which are a Buy (79.08%), 4 which are a Sell (1.67%)

Douglas Tsao

Work Performance Price Targets & Ratings Chart

Analyst Douglas Tsao works at HC WAINWRIGHT and is covering the Healthcare sector with 500 price targets and ratings displayed on 39 stocks. Previously, Douglas Tsao worked at BARCLAYS.

Douglas Tsao's average stock forecast success ratio is 36.33% with an average time for price targets to be met of 108.35 days.

Most recent stock forecast was given on APLS, Apellis Pharmaceuticals at 26-Sep-2023.

Wall Street Analyst Douglas Tsao

Analyst best performing recommendations are on ALKS (ALKERMES PLC).
The best stock recommendation documented was for ALKS (ALKERMES PLC) at 10/26/2017. The price target of $50 was fulfilled within 1 day with a profit of $4.97 (9.04%) receiving and performance score of 90.41.

Average potential price target upside

CHMA MYL JAZZ Jazz Pharmaceuticals plc MNK PCRX Pacira BioSciences TEVA Teva Pharmaceutical Industries AGN ALKS Alkermes plc CERE Cerevel Therapeutics Holdings CHRS Coherus BioSciences CRL Charles River Laboratories International CRNX Crinetics Pharmaceuticals ENDP Endo International plc EOLS Evolus IMVT Immunovant MNTA OSMT Osmotica Pharmaceuticals plc PRAX Praxis Precision Medicines PRGO Perrigo Company plc PTGX Protagonist Therapeutics RDUS Radius Health RVNC Revance Therapeutics SAGE Sage Therapeutics ROIV TBPH Theravance Biopharma TRVN Trevena TXMD TherapeuticsMD ARGX argenx SE AMYT DARE Dare Bioscience APLS Apellis Pharmaceuticals CABA ELYM EVO NERV Minerva Neurosciences OTLK Outlook Therapeutics RVLP RZLT VRDN

Analyst name


Current price target

Potential distance

Previous price target


Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score



$1.24 (32.98%)

2 years 6 months 28 days ago

0/1 (0%)

$1.02 (25.63%)


2 years 10 months 23 days ago

0/1 (0%)

$5.51 (100.36%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Douglas Tsao is most bullish on?

Potential upside of $103.37 has been obtained for ARGX (ARGENX SE)

Which stock is Douglas Tsao is most reserved on?

Potential downside of -$9.39 has been obtained for IMVT (IMMUNOVANT)

What Year was the first public recommendation made by Douglas Tsao?

On 2008

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart